Claims for Patent: 12,290,700

Summary for Patent: 12,290,700

Title:	Adjustable illuminator for photodynamic therapy and diagnosis
Abstract:	An adjustable illuminator for photodynamically diagnosing or treating a surface includes a plurality of first panels and at least one second panel. The plurality of first panels have wider widths and the at least one second panel has a narrower width. The narrower width is less than the wider widths. The illuminator further includes a plurality of light sources, each mounted to one of the plurality of first panels or the at least one second panel and configured to irradiate the surface with substantially uniform intensity visible light. The plurality of first panels and the at least one second panel are rotatably connected. The at least one second panel is connected on each side to one of the plurality of first panels. The second panel acts as a “lighted hinge” to reduce or eliminate optical dead spaces between adjacent panels when the illuminator is bent into a certain configuration.
Inventor(s):	Thomas Boyajian, Mark Carota, Brian Mazejka
Assignee:	Sun Pharmaceutical Industries Inc
Application Number:	US17/889,115
Patent Claims:	1. A method of photodynamically diagnosing or treating a patient, the method comprising: applying 5-aminolevulinic acid (ALA) to a treatment surface on an extremity of the patient, illuminating, by an illuminator comprising a plurality of light sources disposed on surfaces of a plurality of panels, the treatment surface of the patient; wherein the plurality of panels are connected by hinged structures on inner side surfaces of adjacent panels, wherein the illuminator is configured to uniformly illuminate the treatment surface via the light sources; positioning one of the plurality of panels as a center panel to face the treatment surface; and positioning two or more of the plurality of panels to be extended from the center panel such that the plurality of panels are positioned to allow treatment of the extremities of the patient; wherein each of the plurality of panels has two first edges and two second edges shorter than the two first edges, and the light sources are arranged such that a higher intensity of light is emitted proximate the second edges compared to the intensity of light emitted not proximate the second edges. 2. The method of claim 1, wherein illuminating comprises outputting red light at a dose of about 30 J/cm2 to about 150 J/cm2. 3. The method of claim 1, wherein illuminating comprises outputting light at a variable irradiance density during treatment. 4. The method of claim 1, wherein illuminating comprises outputting light at an irradiance density of 10 mW/cm2 to 30 mW/cm2. 5. The method of claim 1, wherein a plurality of the light sources are configured to emit light having a wavelength in a range of 400 nm to 700 nm. 6. The method of claim 1, wherein illuminating comprises controlling illumination from each of the plurality of panels. 7. The method of claim 1, wherein the treatment surface is located on the arms, legs or feet. 8. The method of claim 1, wherein about 2 mg/cm2 of ALA is applied to the treatment surface. 9. A system for photodynamically diagnosing or treating a patient, comprising: an illuminator comprising five panels connected by hinged structures on inner side surfaces of adjacent panels; light sources disposed on the five panels of the illuminator, the light sources being configured to uniformly illuminate a treatment surface of the patient, and a controller and at least one sensor, the controller being configured to change intensities of the light sources of the illuminator with a controller in accordance with information received from the at least one sensor relating to a curvature of the treatment surface, wherein each of the five panels has two first edges and two second edges shorter than the two first edges, and the light sources are arranged such that a higher intensity of light is emitted proximate the second edges compared to the intensity of light emitted not proximate the second edges, wherein each of the five panels is configured to allow selective control of illumination therefrom. 10. The system of claim 9, wherein the light sources are configured to illuminate the treatment surface by outputting red light during at least part of the time when the treatment surface is illuminated. 11. The system of claim 9, wherein the light sources are configured to illuminate the treatment surface by outputting blue light during at least part of the time when the treatment surface is illuminated. 12. The system of claim 9, wherein: the illuminator comprises at least three first panels having first widths, at least two second panels having second widths, wherein each of the second widths of the at least two second panels is narrower than each of the first widths of the at least three first panels; and the at least three first panels and the at least two second panels are connected in an alternating manner such that each of the at least two second panels has a first lateral side connected to a respective one of the at least three first panels and a second lateral side connected to another respective one of the at least three first panels. 13. The system of claim 9, wherein the sensor is configured to determine a size of the treatment surface of the patient. 14. The system of claim 13, wherein the controller is configured to adjust an overall light dose based on the determined size of the treatment surface. 15. The system of claim 13, further comprising at least one actuator configured to adjust positioning of panels based on the determined size of the treatment surface.